ArticleBJUI compass2026
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to develop and evaluate MUSeg-PSV, a real-time deep-learning framework for segmentation of the prostate gland and seminal vesicles on 29-MHz micro-ultrasound (MicroUS), intended to support anatomical orientation during MicroUS-guided prostate biopsy and local staging of prostate cancer. Patients and methods: MicroUS data from 14 patients (21 full-length videos; 2588 annotated frames) were used to train and test MUSeg-PSV, a lightweight single-stage convolutional model based on YOLOv11s-seg. Two training strategies were compared: a standard configuration with basic augmentations and an augmentation-rich configuration incorporating advanced spatial and photometric transformations. Model performance was assessed on a held-out test set using mean average precision (mAP), dice similarity coefficient (DSC), expected calibration error (ECE) and Brier score. Real-time feasibility was evaluated through inference latency and qualitative assessment of temporal consistency on unseen videos. Results: The augmentation-rich model outperformed the standard configuration, yielding a 21% relative increase in mAP and a 4.6-fold improvement in seminal vesicle AP (0.183 → 0.842). Prostate DSC increased from 0.675 to 0.770 ( Conclusion: MUSeg-PSV enables reliable, real-time multiclass segmentation of high-frequency MicroUS, providing stable delineation of the prostate and seminal vesicles at clinically viable frame rates. These results support the potential of AI-assisted MicroUS to enhance operator orientation during MicroUS-guided prostate biopsy and local staging, and to promote standardised identification of seminal vesicles within prostate cancer diagnostic and staging workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.